Safety and efficacy outcomes of the Xen45 Gel Stent use for refractory glaucoma: a surgery series from surgeon trainees at a tertiary teaching hospital

BACKGROUND: To study the effect of an ab interno gelatin stent (XEN45 Gel Stent, Allergan Inc., Irvine, California, USA) on intraocular pressure (IOP) as placed by glaucoma fellowship trainees in eyes with refractory glaucoma. METHODS: A prospective noncomparative study at a tertiary training center...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Karen, Lind, John, Sheybani, Arsham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995155/
https://www.ncbi.nlm.nih.gov/pubmed/32021876
http://dx.doi.org/10.1186/s40662-019-0171-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995155/
https://www.ncbi.nlm.nih.gov/pubmed/32021876
http://dx.doi.org/10.1186/s40662-019-0171-0

Ejemplares similares